Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
02/05/2024 16:53
May 2 (Reuters) - Crossject SA 74C.F :
* CROSSJECT SIGNS A GEOGRAPHIC EXTENSION OF ZEPIZURE®
COMMERCIALIZATION AGREEMENT IN EUROPE
* CROSSJECT SA - TO RECEIVE UP TO €1M IN MILESTONE PAYMENTS
Source text for Eikon: ID:nGNX2Wy0cf
Further company coverage: 74C.F
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure